...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

Great post narmac. Thanks for sharing.

So this pretty much dispells old man "Mr Excitment's" dillusions about the financial markets being the reason he has achieved nothing in 5 years!      :)

Time to bring in a competent CEO.

In Don's recent pitch he emphasized with a degree of pride that there has been little turn over in his executive team in their 21 year existence. While I personally feel this is a good sign I've also watched corporate cultures become ineffective because they are all reinforcing their own bad policies...i.e. a "yes men" environment. It's time for a change.

GLTA 

Toinv

Share
New Message
Please login to post a reply